healthprotocol.wiki

Home/Protocols/therapy/stem

Protocol group

therapy-stem

4 protocols · 15 outcomes with evidence

Subgroups

Protocols (4)

Outcomes & scoring

acute-graft-versus-host-disease-grade-ii-iv-cumulative-incidence1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-70	60	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+70	60	97

acute-graft-versus-host-disease-grade-iii-iv-cumulative-incidence1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-75	60	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+75	60	97

chronic-graft-versus-host-disease-cumulative-incidence1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-90	65	189
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+90	65	97

hematology-bone-marrow-no-abnormal-cells-day-45-post-transplant-achieved-binary-measured1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-allogeneic-spleen-irradiation-chronic-myelomonocytic-leukemia-protocol	+90	50	1

hematology-cumulative-incidence-of-neutrophil-engraftment-at-30-days-percent1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-ex-vivo-fucosylation-cord-blood-hematopoietic-cells-fucosyltransferase-vi-gdp-fucose-double-cord-blood	+50	50	22

hematology-cumulative-incidence-of-platelet-engraftment-at-65-days-percent1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-ex-vivo-fucosylation-cord-blood-hematopoietic-cells-fucosyltransferase-vi-gdp-fucose-double-cord-blood	+65	50	22

hematology-time-to-neutrophil-engraftment-anc-500-per-microliter1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-30	55	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+30	55	97

hematology-time-to-neutrophil-engraftment-days1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-ex-vivo-fucosylation-cord-blood-hematopoietic-cells-fucosyltransferase-vi-gdp-fucose-double-cord-blood	+60	50	22

hematology-time-to-platelet-engraftment-20k-per-microliter1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-60	60	190
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+60	60	97

hematology-time-to-platelet-engraftment-days1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-ex-vivo-fucosylation-cord-blood-hematopoietic-cells-fucosyltransferase-vi-gdp-fucose-double-cord-blood	+50	50	22

oncology-relapse-cumulative-incidence1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-40	55	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+40	55	97

survival-graft-versus-host-disease-free-relapse-free-probability1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-30	55	187
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+30	55	97

survival-overall-probability1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	0	50	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	0	50	97

survival-progression-free-probability1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	-15	45	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	+15	45	97

survival-treatment-related-mortality-cumulative-incidence1 evidence row

Protocol	Effect	Confidence	N
therapy-stem-cell-transplant-double-umbilical-cord-blood-reduced-intensity-conditioning-fludarabine-cyclophosphamide-low-dose-total-body-irradiation	+10	40	193
therapy-stem-cell-transplant-haplo-cord-reduced-intensity-conditioning-fludarabine-melphalan-anti-thymocyte-globulin	-10	40	97

Path: therapy › stem